Definer DF2000 Knife Mill from Franklin Miller Offers Ease of Use
The device focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up.
The Definer DF2000 knife mill from Franklin Miller focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up. The company introduced the product on Nov. 14, 2019.
The device’s rotor design comes equipped with replaceable rotary knife elements and several cutter elements and screen sizes that allow for the customization of the condition, mill, and deagglomerate of the device. The stainless-steel hopper and protective flaps help to keep work environments clean, while the rotational speed, particle size, and throughput are maintained with the knife mill’s variable speed controller. Additional add-ons are also available and include casters with lockable wheels and a pneumatic discharge system.
Source: Franklin Miller
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
